Hester Biosciences Q4 net profit up by 37% at 14.55 crore

www.newsbarons.com

The board has recommended an additional final dividend of INR 7 per equity share (70%) for FY19, subject to the approval of the shareholders.

Hester Biosciences announced it Q4 2019 and FY19 results.

Business Overview

Q4FY19 Results:

Sales up by 30%

Profit up by 37%

FY19 Results:

Sales up by 27%

Profit up by 44%

The board of directors had declared and paid an interim dividend of INR 2 per equity share (20%) in Q1FY19 as well as on Q2FY19, totaling to INR 4 per equity share (40%).

The board has further recommended an additional final dividend of INR 7 per equity share (70%) for FY19, subject to the approval of the shareholders.

Total Dividend therefore for FY19would be INR 11 per equity share (110%) as against the INR 10per equity share (100%) for FY18.

Financial Highlights